Clinical Study

A Simple Clinical Measure of Quadriceps Muscle Strength Identifies Responders to Pulmonary Rehabilitation

Table 1

Baseline assessment data for responders compared to nonresponders in the six minute walk distance.

(A) Responders (A) Nonresponders(B) Responders(B) Nonresponders

Number (%)49 (57.6%)36 (42.4%)19 (22.4%)66 (77.6%)
Age (years)
FEV1% predicted
mMRC
Quadriceps strength (%)
Physical activity level (METs)+
Interleukin-8 (pg/mL)*
C Reactive Protein (pg/mL)*
COPD self-efficacy score 3.0 ± 0.8
Charlson comorbidity index1.9 ± 1.1
Metabolic disease15/49 (31%)10/36 (28%) 11/19 (31%)14/66 (28%)
Cardiac disease13/49 (27%)12/36 (33%) 5/19 (26%)20/66 (30%)
Musculoskeletal disease 18/49 (37%)9/36 (25%) 10/19 (31%)17/66 (28%)
Baseline 6MWD (m)

Part (A) responders/non-responders used the criteria of six-minute walk distance (6MWD) ≥25 m. Part (B) responders/non-responders used the criteria of 6MWD ≥61.9 m. Data expressed as the mean ± standard deviation. FEV1: forced expiratory volume in one second, mMRC: modified Medical Research Council dyspnea scale, and METs: metabolic equivalent of task.
Systemic inflammatory markers were assessed in 77 participants.
Physical activity level was assessed in 46 participants.